A. Schottelius

发表

Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB

M. Mayo, Cun-Yu Wang, L. Madrid, 2000, Molecular and Cellular Biology.

A role for transcription factor NF-kB in intestinal inflammation

A. Schottelius, A. S. Baldwin Jr, A. S. Baldwin Jr., 1999, International Journal of Colorectal Disease.

SEGRAs: a novel class of anti-inflammatory compounds.

K. Asadullah, A. Schottelius, H. Schäcke, 2002, Ernst Schering Research Foundation workshop.

An Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile

K. Asadullah, A. Schottelius, S. Colgan, 2002, The Journal of Immunology.

Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo.

A. Schottelius, D. Davey, C. Mallari, 2004, Journal of medicinal chemistry.

Anti-Inflammatory Profile Analog Displays a Unique Topical Stable 4 An Aspirin-Triggered Lipoxin A

K. Asadullah, A. Schottelius, S. Colgan, 2002 .

Cellular Differentiation Causes a Selective Down-regulation of Interleukin (IL)-1β-mediated NF-κB Activation and IL-8 Gene Expression in Intestinal Epithelial Cells*

D. Brenner, A. Schottelius, R. Sartor, 2000, The Journal of Biological Chemistry.

Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers.

J. Koch, P. Carter, A. Schottelius, 2022, Trends in immunology.

Visualizing CD4 T‐cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model

C. Elmets, H. Hsu, Pingar Yang, 2010, The British journal of dermatology.

The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.

K. Asadullah, M. Gaestel, A. Schottelius, 2010, The Journal of investigative dermatology.

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

K. Asadullah, A. Schottelius, W. Döcke, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding*

M. Mayo, A. Baldwin, A. Schottelius, 1999, The Journal of Biological Chemistry.

Biology of tumor necrosis factor‐α– implications for psoriasis

Khusru Asadullah, Wolfram Sterry, K. Asadullah, 2004, Experimental dermatology.

Cytokines, NF-κB, Microenvironment, Intestinal Inflammation and Cancer

A. Schottelius, H. Dinter, Harald Dinter, 2006 .

Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease

F. Buttgereit, W. Rohde, A. Schottelius, 2000, American Journal of Gastroenterology.

Mechanisms of p53 alteration in acute leukemias.

F. Herrmann, R. Mertelsmann, M. Lübbert, 1994, Leukemia.

Molecular mechanisms of interleukin‐10‐mediated inhibition of NF‐κB activity: a role for p50

K. Asadullah, A. Schottelius, F. Driessler, 2004, Clinical and experimental immunology.

Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

J. Hampe, P. Rosenstiel, A. Schottelius, 2002, Gut.

glycosyltransferase genes memory CD4+ T cells: evidence for epigenetic regulation of involved Differential regulation of P-selectin ligand expression in naive versus

Andreas Radbruch, A. Schottelius, A. Hamann, 2013 .

Differential regulation of P-selectin ligand expression in naive versus memory CD4+ T cells: evidence for epigenetic regulation of involved glycosyltransferase genes.

Andreas Radbruch, A. Schottelius, A. Hamann, 2004, Blood.

ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.

Y. Xiong, T. Ohta, A. Schottelius, 1999, Molecular cell.

Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding.

M. Mayo, A. Baldwin, A. Schottelius, 1999, The Journal of biological chemistry.

From Bench to Bedside: Bringing Understanding of Cutaneous T-Cell Recruitment to Patients

K. Asadullah, A. Schottelius, T. Zollner, 2004 .

A miniaturized high-throughput screening assay for fucosyltransferase VII.

B. Müller-Tiemann, A. Schottelius, A. Ernst, 2008, Analytical biochemistry.

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial

P. Tak, A. Schottelius, M. Østergaard, 2014, Annals of the rheumatic diseases.

First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1b/2a randomized, double-blind, placebo-controlled trial

P. Tak, A. Schottelius, T. Huizinga, 2012 .

Role of fucosyltransferases in leukocyte trafficking: major impact for cutaneous immunity.

K. Asadullah, A. Schottelius, A. Hamann, 2003, Trends in immunology.

Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.

A. Schottelius, H. Dinter, 2006, Cancer treatment and research.

A role for transcription factor NF-kappa B in intestinal inflammation.

A. Baldwin, A. Schottelius, 1999, International journal of colorectal disease.

INFLAMMATION AND INFLAMMATORY BOWEL DISEASE Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

A. Schottelius, D. Seegert, T. Kühbacher, 2002 .